Literature DB >> 14504831

Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.

Hendrik Everaert1, Christian Vanhove, Tony Lahoutte, Kristoff Muylle, Vicky Caveliers, Axel Bossuyt, Philippe R Franken.   

Abstract

Reducing the acquisition time of whole-body fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) (corrected for attenuation) is of major importance in clinical practice. With the introduction of lutetium oxyorthosilicate (LSO), the acquisition time can be dramatically reduced, provided that patients are injected with larger amounts of tracer and/or the system is operated in 3D mode. The aim of this study was to determine the optimal dose of 18F-FDG required in order to achieve good-to-excellent image quality when a "3-min emission, 2-min transmission/bed position" protocol is used for an LSO PET camera. A total of 218 consecutive whole-body 18F-FDG PET studies were evaluated retrospectively. After excluding patients with liver metastases, hyperglycaemia and paravenous injections, the final study population consisted of 186 subjects (112 men, 74 women, age 59 +/- 15 years). Patients were injected with an activity of 18F-FDG ranging from 2.23 to 15.21 MBq/kg. Whole-body images corrected for attenuation (3 min emission, 2 min transmission/bed position) were acquired with an LSO PET camera (Ecat Accel, Siemens) 60 min after tracer administration. Patients were positioned with their arms along the body. Image reconstruction was done iteratively and a post-reconstruction filter was applied. Image quality was scored visually by two independent observers using a five-point scoring scale (poor, reasonable, good, very good, excellent). In addition, the coefficient of variability (COV) was measured in a region of interest over the liver in order to quantify noise. Of the images obtained in 118 patients injected with > or =8 MBq/kg 18F-FDG, 92% and 90% were classified as good, very good or excellent by observer 1 and observer 2, respectively. The COV averaged 10.63% +/- 3.19% for doses > or =8 MBq/kg and 16.46% +/- 5.14% for doses <8 MBq/kg. Administration of an 18F-FDG dose of > or =8 MBq/kg results in images of good to excellent quality in the vast majority of patients when using an LSO PET camera and applying a 3-min emission, 2-min transmission/bed position acquisition protocol. At lower doses, a rapid decline in image quality and increasing noise are observed. Alternative protocols should be adopted in order to compensate for the loss in image quality when doses <8 MBq/kg are used.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504831     DOI: 10.1007/s00259-003-1317-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  3 in total

1.  For: Is LSO the future of PET?

Authors:  Ronald Nutt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11       Impact factor: 9.236

2.  Optimization of injected dose based on noise equivalent count rates for 2- and 3-dimensional whole-body PET.

Authors:  Carole Lartizien; Claude Comtat; Paul E Kinahan; Nuno Ferreira; Bernard Bendriem; Régine Trébossen
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

3.  3D PET using a conventional multislice tomograph without septa.

Authors:  S R Cherry; M Dahlbom; E J Hoffman
Journal:  J Comput Assist Tomogr       Date:  1991 Jul-Aug       Impact factor: 1.826

  3 in total
  11 in total

1.  Source of impaired image quality in 3D whole-body FDG PET scanning.

Authors:  Anne M J Paans; Sabine M M Boerdijk; Antoon T M Willemsen; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-10       Impact factor: 9.236

2.  Optimization of injection dose based on noise-equivalent count rate with use of an anthropomorphic pelvis phantom in three-dimensional 18F-FDG PET/CT.

Authors:  Kazumasa Inoue; Hideo Kurosawa; Takashi Tanaka; Masahiro Fukushi; Noriyuki Moriyama; Hirofumi Fujii
Journal:  Radiol Phys Technol       Date:  2011-12-30

3.  Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner.

Authors:  D Visvikis; D Griffiths; D C Costa; J Bomanji; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-22       Impact factor: 9.236

4.  An evaluation of DNA double strand break formation and excreted guanine species post whole body PET/CT procedure.

Authors:  Tanmoy Mondal; Amit Nautiyal; Somiranjan Ghosh; Christopher A Loffredo; Deepanjan Mitra; Chabita Saha; Subrata Kumar Dey
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

5.  Dose Optimization in TOF-PET/MR Compared to TOF-PET/CT.

Authors:  Marcelo A Queiroz; Gaspar Delso; Scott Wollenweber; Timothy Deller; Konstantinos Zeimpekis; Martin Huellner; Felipe de Galiza Barbosa; Gustav von Schulthess; Patrick Veit-Haibach
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens.

Authors:  Jan H Geismar; Paul Stolzmann; Bert-Ram Sah; Irene A Burger; Burkhardt Seifert; Gaspar Delso; Gustav K von Schulthess; Patrick Veit-Haibach; Lars Husmann
Journal:  Acta Radiol Open       Date:  2015-01-29

7.  Clinical image quality perception and its relation to NECR measurements in PET.

Authors:  Marcelo A Queiroz; Scott D Wollenweber; Gustav von Schulthess; Gaspar Delso; Patrick Veit-Haibach
Journal:  EJNMMI Phys       Date:  2014-12-23

8.  Optimized dose regimen for whole-body FDG-PET imaging.

Authors:  Eleonore H de Groot; Nieky Post; Ronald Boellaard; Nils Rl Wagenaar; Antoon Tm Willemsen; Jorn A van Dalen
Journal:  EJNMMI Res       Date:  2013-08-12       Impact factor: 3.138

9.  Technical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines.

Authors:  Daniëlle Koopman; Jochen A C van Osch; Pieter L Jager; Carlijn J A Tenbergen; Siert Knollema; Cornelis H Slump; Jorn A van Dalen
Journal:  EJNMMI Phys       Date:  2016-09-29

10.  Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET/CT: clinical implications for the assessment of lung tumors.

Authors:  Michael Messerli; Paul Stolzmann; Michèle Egger-Sigg; Josephine Trinckauf; Stefano D'Aguanno; Irene A Burger; Gustav K von Schulthess; Philipp A Kaufmann; Martin W Huellner
Journal:  EJNMMI Phys       Date:  2018-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.